Загрузка...
Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time
Defects in antigen presenting cell function have been implicated in glioma immunosuppression. We measured peripheral CCL22, a dendritic cell/macrophage derived T cell trafficking chemokine, in sera from 1,208 glioma cases and 976 controls to assess whether it might provide a biomarker of glioma risk...
Сохранить в:
| Опубликовано в: : | Int J Cancer |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4478165/ https://ncbi.nlm.nih.gov/pubmed/25604093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.29441 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|